Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer.
FORT-2 trial shows promising results for bladder cancer immunotherapy combination
- Post author:
- Post published:September 19, 2024
- Post category:uncategorized